Introduction
============

Gene duplication results in genetic redundancy; in other words, the existence of genetic elements that encode for the same function. It is a powerful process that can regulate gene expression, increase the genetic and environmental robustness of organisms, and act as a stepping stone to the evolution of new biological functions. Therefore, it is not surprising that gene duplication is a frequent phenomenon in many organisms ([@evw219-B50]; [@evw219-B1]). Despite these clear advantages, there are few examples of genetic redundancy in viral genomes. In general, viral genomes tend to be highly streamlined, with limited intergenic sequences and in many cases overlapping open reading frames (ORFs), suggesting that genome size is under strong selection ([@evw219-B26]). Therefore, it is not surprising that gene duplications appear to be relatively frequent only in the large DNA viruses ([@evw219-B35]; [@evw219-B39]). RNA viruses typically have smaller genomes (ranging from ∼2 kb to ∼33 kb) than DNA viruses (ranging from the ∼1.7 kb of circoviruses to the ∼2.5 Mb of the giant pandoraviruses) ([@evw219-B8]), and consequently there is an extremely low prevalence of gene duplication in RNA viruses ([@evw219-B4], [@evw219-B5]; [@evw219-B36]). For the reverse-transcribing viruses, three different gene duplication events have been reported within the *Retroviridae* family ([@evw219-B41]; [@evw219-B24]; [@evw219-B20]). This low prevalence of gene duplication in retroviruses is surprising, because repeated sequence elements of endogenous retroviruses are thought to mediate genomic rearrangements, including gene duplication ([@evw219-B19]). For the ss(-)RNA viruses, two different tandem gene duplications have been reported ([@evw219-B48]; [@evw219-B17]; [@evw219-B6]; [@evw219-B36]) within the *Rhabdoviridae* (infecting vertebrates, invertebrates, and plants). For the ss(+)RNA viruses, single duplication events have been reported for four different domains: (i) a tandem duplication of the coat protein gene (*CP*) within the *Closteroviridae* (infecting plants) ([@evw219-B7]; [@evw219-B15]; [@evw219-B22]; [@evw219-B46]; [@evw219-B45]; [@evw219-B36]); (ii) a tandem duplication of the genome-linked protein gene (*VPg*) in *Foot-and-mouth disease virus* from the *Picornaviridae* (infecting vertebrates) ([@evw219-B16]); (iii) a duplication of the third segment, generating an additional one, in *Beet necrotic yellow vein virus* from the *Benyviridae* (infecting plants) ([@evw219-B36]); and (iv) a tandem duplication of the *P1* gene in *Cucumber vein yellowing virus* from the *Potyviridae* (infecting plants) ([@evw219-B47]). In the latter case, the two *P1* copies resemble two different genera types within the family, suggesting that both recombination and gene duplication have contributed to *P1* evolution. To date, no cases of gene duplication in dsRNA viruses have been reported.

The variation in genome size and structure indicates that gene duplication must have played a role in the early diversification of viral genomes. However, the rapid evolution of RNA viruses and the potential fitness costs associated with harboring additional genetic material probably makes it unlikely to detect viruses with duplications, or even the signatures of recent duplication events. Strong selective constraints against increasing genome sizes are thought to play a role in the lack of gene duplications that we nowadays observe in RNA viruses ([@evw219-B18]; [@evw219-B4], [@evw219-B5]). One of these constraints is the high mutation rates of RNA viruses, which is approximately one mutation per genome and per replication event ([@evw219-B33]). Another constraint is the need for fast replication due to strong within-cell and within-host competition ([@evw219-B44]). On the other hand, the small and streamlined RNA virus genomes also limit sequence space for the evolution of novel functions, and in turn adaptation to environmental changes.

Here, we therefore consider experimentally the evolutionary fate of gene duplications in viral genomes, in terms of their effects on fitness, the stability of the duplicated gene and the evolvability of these viruses. We choose to work with *Tobacco etch virus* (TEV; genus *Potyvirus*, family *Potyviridae*). This plant pathogen has a monopartite ss(+)RNA genome, of about 9.5 kb in length ([@evw219-B31]). It codes for a single ORF (i.e., polyprotein) that is further processed after translation into ten mature peptides, in addition the *P3N-PIPO* ORF is translated at a +2 frameshift within the *P3* cistron ([fig. 1A](#evw219-F1){ref-type="fig"}). We experimentally explore four cases of homologous duplication of genes within the TEV genome: (i) the multi-functional protein (HC-Pro) involved in aphid transmission, polyprotein cleavage, genome amplification, and suppression of RNA silencing, (ii) the main viral protease (NIa-Pro), (iii) the viral RNA-dependent RNA polymerase (NIb), and (iv) the coat protein (CP). Potyviruses are a particularly interesting system for studying the evolution of gene duplications, as for each complete ss(+)RNA there will be isostoichiometric expression of all genes. Assuming there are no unknown mechanisms that regulate gene expression, the scope for the regulation of gene expression in potyviruses could therefore be very limited. Gene duplication may represent a way to bypass these constraints and achieve higher expression of specific genes.

![Schematic representation of the different TEV genotypes containing gene duplications. The wild-type TEV (*A*) codes for 11 mature peptides, including P3N-PIPO embedded within the P3 protein at a +2 frameshift. Five different viral genotypes containing a single gene duplication were constructed. Second copies of *HC-Pro* (*B*), *NIa-Pro* (*C*), and *NIb* (*D*) were introduced between *P1* and *HC-Pro*. A second copy of *NIb* was also introduced before *P1* (*D*). And a second copy of *CP* was introduced between *NIb* and *CP* (*E*). For simplification P3N-PIPO is only drawn at the wild-type TEV.](evw219f1p){#evw219-F1}

We speculated that the duplication of these four proteins might have widely different impacts on TEV fitness. As HC-Pro is a multifunctional protein, two copies of HC-Pro could lead to specific improvement of one or more of its functions. This potential improvement could possibly be caused by two mechanisms. First, by simply producing more protein there could be an immediate benefit for one of HC-Pro's functions. Second, there could be improvement of protein function when the duplicated virus is evolved, because the two gene copies can diverge and specialize on different functions. Higher levels of NIa-Pro may result in a more efficient processing of the polyprotein, making more mature viral proteins available faster for the replication process. As potyviruses have only a limited number of post-translational mechanisms for regulating gene expression levels, we predicted that the overproduction of NIa-Pro will alter the equilibrium concentrations of all the different mature peptides and thus have a major impact in TEV fitness. Higher levels of NIb may result in higher levels of transcription and faster replication of the virus and this could lead to higher levels of genome accumulation and potentially the within-host spread of infection by a greater number of virions. The cellular multiplicity of infection (MOI), which has been estimated to be as low as 1.14 virions per infected cell for TEV ([@evw219-B42]), might even increase. Higher levels of CP expression could allow for the encapsidation of more genomic RNA molecules without affecting the accumulation of all other mature peptides. However, in all these cases completion of the infectious cycle would still depend on the cytoplasmic amount of other limiting viral (e.g., P1, P3, CI, and VPg) or host proteins.

The duplication events that we explore here could therefore conceivably have beneficial effects on TEV replication, perhaps offsetting the costs inherent to a larger genome and thereby increasing overall fitness. Moreover, especially in the case of HC-Pro, they could perhaps lead to the evolution of greatly improved or novel functions. However, given the scarcity of gene duplications in RNA viruses, we expected that the fitness costs of duplication are likely to be high, and that one of the two gene copies would be rapidly lost. If further mutations could potentially help accommodate the duplicated gene, then this could lead to interesting evolutionary dynamics: will the duplicated gene be lost or will beneficial mutations that lead to stable maintenance of the gene occur first? ([@evw219-B53]). Moreover, as they could potentially disrupt correct processing of the polyprotein, the possibility that some of the duplications would not be viable in the first place could also not be discounted ([@evw219-B27]). To address these issues we have constructed four viruses with gene duplications and tested their viability. We subsequently evolved these viruses and determined the stability of the duplicated gene, as well as looking for signals of accommodation of the duplicated gene. Finally, we built a mathematical model to estimate key parameters from the experimental data, such as the recombination rates responsible for the deletion of duplicated genes, and to explore the evolutionary dynamics and stability conditions of the system.

Materials and Methods
=====================

Viral Constructs, Virus Stocks and Plant Infections
---------------------------------------------------

The TEV genome used to generate the virus constructs, was originally isolated from *Nicotiana tabacum* plants ([@evw219-B10]). In this study five different variants of TEV were used containing single gene duplications. Two of these virus variants, TEV-NIb~1~-NIb~9~ and TEV-NIb~2~-NIb~9~ were generated in a previous study ([@evw219-B49]). The other three variants were generated in this study: TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~, and TEV-CP~10~-CP~11~. The TEV-HCPro~2~-HCPro~3~ and TEV-CP~10~-CP~11~ viruses contain gene duplications in tandem.

TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~, and TEV-CP~10~-CP~11~ were generated from cDNA clones constructed using plasmid pMTEVa, which consists of a TEV infectious cDNA (accession: DQ986288, including two silent mutations, G273A and A1119G) flanked by SP6 phage RNA promoter derived from pTEV7DA (GenBank: DQ986288). pMTEVa contains a minimal transcription cassette to ensure a high plasmid stability ([@evw219-B3]). The clones were constructed using standard molecular biology techniques, including PCR amplification of cDNAs with the high-fidelity Phusion DNA polymerase (Thermo Scientific), DNA digestion with *Eco*31I (Thermo Scientific) for assembly of DNA fragments ([@evw219-B14]), DNA ligation with T4 DNA ligase (Thermo Scientific) and transformation of *Escherichia coli* DH5α by electroporation. Sanger sequencing confirmed the sequences of the resulting plasmids.

The plasmids of TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~ and TEV-CP~10~-CP~11~ were linearized by digestion with *Bgl*II prior to *in vitro* RNA synthesis using the mMESSAGE mMACHINE^®^ SP6 Transciption Kit (Ambion), as described in [@evw219-B9]. The third true leaf of 4-week-old *N. tabacum* L. cv Xanthi *NN* plants was mechanically inoculated with varying amounts (5--30 μg) of transcribed RNA. All symptomatic tissue was collected 7 dpi (days post inoculation) and stored at −80 °C as stock tissue.

Serial Passages
---------------

For the serial passage experiments, 500 mg homogenized stock tissue was ground into fine powder using liquid nitrogen and a mortar, and resuspended in 500 μl phosphate buffer (50 mM KH~2~PO~4~, pH 7.0, 3% polyethylene glycol 6000). From this mixture, 20 μl were then mechanically inoculated on the third true leaf of 4-week old *N. tabacum* plants. At least five independent replicates were performed for each virus variant. At the end of the designated passage duration (3 or 9 weeks) all leaves above the inoculated leaf were collected and stored at −80 °C. For subsequent passages, the frozen tissue was homogenized and a sample of the homogenized tissue was ground and resuspended with an equal amount of phosphate buffer ([@evw219-B53]). Then, new *N. tabacum* plants were mechanically inoculated as described above. The plants were kept in a BSL-2 greenhouse at 24 °C with 16 h light.

Reverse Transcription Polymerase Chain Reaction (RT-PCR)
--------------------------------------------------------

The wild-type TEV produces characteristic symptoms in the host plant. However, some of the altered genotypes show few or no symptoms and virus infection had to be confirmed by RT-PCR. To confirm infection and to determine the stability of the duplicated genes, RNA was extracted from 100 mg homogenized infected tissue using the InviTrap Spin Plant RNA Mini Kit (Stratec Molecular). Reverse transcription (RT) was performed using MMuLV reverse transcriptase (Thermo Scientific) and the reverse primer 5′-CGCACTACATAGGAGAATTAG-3′ located in the 3′UTR of the TEV genome. PCR was then performed with *Taq* DNA polymerase (Roche) and primers flanking the region containing the duplicated gene copy ([supplementary table S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). To test whether the ancestral gene copy was intact this region was also amplified for TEV-NIaPro~2~-NIaPro~8~, TEV-NIb~1~-NIb~9~, and TEV-NIb~2~-NIb~9~ viruses, where the duplicated genes are not located in tandem ([supplementary table S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). PCR products were resolved by electrophoresis on 1% agarose gels. For those virus populations in which we detected deletions during the evolution experiment, we estimated the genome size based on the amplicon size and the genome size of the ancestral viruses.

Fitness Assays
--------------

The genome equivalents per 100 mg of tissue of the ancestral virus stocks and all evolved lineages were determined for subsequent fitness assays. The InviTrap Spin Plant RNA Mini Kit (Stratec Molecular) was used to isolate total RNA from 100 mg homogenized infected tissue. Real-time quantitative RT-PCR (RT-qPCR) was performed using the One Step SYBR PrimeScript RT-PCR Kit II (Takara), in accordance with manufacturer instructions, in a StepOnePlus Real-Time PCR System (Applied Biosystems). Specific primers for the *CP* gene were used; forward 5′-TTGGTCTTGATGGCAACGTG-3′ and reverse 5′-TGTGCCGTTCAGTGTCTTCCT-3′. The StepOne Software v.2.2.2 (Applied Biosystems) was used to analyze the data. The concentration of genome equivalents per 100 mg of tissue was then normalized to that of the sample with the lowest concentration, using phosphate buffer.

For the accumulation assays, 4-week-old *N. tabacum* plants were inoculated with 50 μl of the normalized dilutions of ground tissue. For each ancestral and evolved lineage, at least three independent plant replicates were used. Leaf tissue was harvested 7 dpi. Total RNA was extracted from 100 mg of homogenized tissue. Virus accumulation was then determined by means of RT-qPCR for the *CP* gene of the ancestral and the evolved lineages. For each of the harvested plants, at least three technical replicates were used in the RT-qPCR.

To measure within-host competitive fitness, we used TEV carrying an enhanced green fluorescent protein (TEV-eGFP) ([@evw219-B3]) as a common competitor. TEV-eGFP has proven to be stable up to 6 weeks (using 1- and 3-week serial passages) in *N. tabacum* ([@evw219-B53]), and is therefore not subjected to appreciable eGFP loss during our 1-week long competition experiments. All ancestral and evolved viral lineages were again normalized to the sample with the lowest concentration, and 1:1 mixtures of viral genome equivalents were made with TEV-eGFP. The mixture was mechanically inoculated on the same species of host plant on which it had been evolved, using three independent plant replicates per viral lineage. The plant leaves were collected at 7 dpi, and stored at −80 °C. Total RNA was extracted from 100 mg homogenized tissue. RT-qPCR for the *CP* gene was used to determine total viral accumulation, and independent RT-qPCR reactions were also performed for the *eGFP* sequence using primers forward 5′-CGACAACCACTACCTGAGCA-3′ and reverse 5′-GAACTCCAGCAGGACCATGT-3′. The ratio (*R*) of the evolved and ancestral lineages to TEV-eGFP is then $R = {\left( {n_{CP} - \, n_{eGFP}} \right)/n_{eGFP}}$, where *n*~CP~ and *n*~eGFP~ are the RT-qPCR measured copy numbers of *CP* and *eGFP*, respectively. Within-host competitive fitness can then be estimated as $W = \sqrt[t]{R_{t}/R_{0}}$, where *R*~0~ is the ratio at the start of the experiment and *R*~t~ the ratio after *t* days of competition ([@evw219-B9]). Note that the method for determining *R* only works well when the frequency of the common is below ∼0.75. This limitation was not problematic though, because in these experiments the fitness of the evolved virus populations remained the same or increased. The statistical analyses comparing the fitness between lineages were performed using R v.3.2.2 ([@evw219-B30] and IBM SPSS Statistics version 23.

Sanger Sequencing
-----------------

For those evolved virus populations in which deletions were detected by RT-PCR, the exact positions of these deletions were determined. The genomes were partly sequenced by the Sanger method. RT was performed using AccuScript Hi-Fi (Agilent Technologies) reverse transcriptase and a reverse primer outside the region to be PCR-amplified for sequencing ([supplementary table S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). PCR was then performed with Phusion DNA polymerase (Thermo Scientific) and primers flanking the deletions ([supplementary table S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Sanger sequencing was performed at GenoScreen (Lille, France: [www.genoscreen.com](http://www.genoscreen.com); last accessed April 10, 2016) with an ABI3730XL DNA analyzer. For TEV-HCPro~2~-HCPro~3~, six sequencing reactions were done per lineage using the same outer reverse primer as used for PCR amplification plus five inner primers ([supplementary table S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). For TEV-NIaPro~2~-NIaPro~8~, three sequencing reactions were done per lineage using three inner primers ([supplementary table S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). For TEV-NIb~1~-NIb~9~ and TEV-NIb~2~-NIb~9~, six sequencing reactions were done per lineage using the same two outer primers as used for PCR amplification plus four inner primers ([supplementary table S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). For TEV-CP~10~-CP~11~, two sequencing reactions were done per lineage using the same two outer primers as used for PCR amplification ([supplementary table S2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Sequences were assembled using Geneious v.8.0.3 ([www.geneious.com](http://www.geneious.com); last accessed April 10, 2016) and the start and end positions of the deletions were determined. Based on the ancestral reference sequences, new reference sequences were constructed containing the majority deletion variant for each of the evolved lineages.

Illumina Sequencing, Variants, and SNP Calling
----------------------------------------------

For Illumina next-generation sequencing (NGS) of the evolved and ancestral lineages, the viral genomes were amplified by RT-PCR using AccuScript Hi-Fi (Agilent Technologies) reverse transcriptase and Phusion DNA polymerase (Thermo Scientific), with six independent replicates that were pooled. Each virus was amplified using three primer sets generating three amplicons of similar size (set 1: 5′-GCAATCAAGCATTCTACTTCTATTGCAGC-3′ and 5′-TATGGAAGTCCTGTGGATTTTCCAGATCC-3′; set 2: 5′-TTGACGCTGAGCGGAGTGATGG-3′ and 5′-AATGCTTCCAGAATATGCC-3′; set 3: 5′-TCATTACAAACAAGCACTTG-3′, and 5′-CGCACTACATAGGAGAATTAG-3′). Equimolar mixtures of the three PCR products were made. Sequencing was performed at GenoScreen. Illumina HiSeq2500 2 × 100 bp paired-end libraries with dual-index adaptors were prepared along with an internal PhiX control. Libraries were prepared using the Nextera XT DNA Library Preparation Kit (Illumina Inc.). Sequencing quality control was performed by GenoScreen, based on PhiX error rate and Q30 values.

Read artifact filtering and quality trimming (3′ minimum Q28 and minimum read length of 50 bp) was done using FASTX-Toolkit v.0.0.14 (<http://hannonlab.cshl.edu/fastx_toolkit/index.html>, last accessed April 10, 2016). De-replication of the reads and 5′ quality trimming requiring a minimum of Q28 was done using PRINSEQ-lite v.0.20.4 ([@evw219-B34]). Reads containing undefined nucleotides (N) were discarded. As an initial mapping step, the evolved sequences were mapped using Bowtie v.2.2.6 ([@evw219-B23]) against their corresponding ancestral sequence: TEV (GenBank accession number KX137149), TEV-HCPro~2~-HCPro~3~ ancestral (GenBank accession number KX137150), TEV-NIaPro~2~-NIaPro~8~ ancestral (GenBank accession number KX137151), TEV-NIb~1~-NIb~9~ ancestral (GenBank accession number KT203712), TEV-NIb~2~-NIb~9~ ancestral (GenBank accession number KT203713), and against the evolved lineages including the corresponding deletions in the lineages where they are present. Subsequently, mutations were detected using SAMtools' mpileup ([@evw219-B25]) in the evolved lineages as compared with their ancestral lineage. At this point, we were only interested in mutations at a frequency \>10%. Therefore, we present frequencies as reported by SAMtools, which has a low sensitivity for detecting low-frequency variants ([@evw219-B38]).

After the initial pre-mapping step, error correction was done using Polisher v2.0.8 (available for academic use from the Joint Genome Institute) and consensus sequences were defined for every lineage. Subsequently, the cleaned reads were remapped using Bowtie v.2.2.6 against the corresponding consensus sequence for every lineage. For each new consensus, Single nucleotide polymorphisms (SNPs) within each virus population were identified using SAMtools' mpileup and VarScan v.2.3.9 ([@evw219-B21]). For SNP calling maximum coverage was set to 40000 and SNPs with a frequency \<1% were discarded.

Modeling the Stability of Gene Insertions
-----------------------------------------

We developed a mathematical model to fit with the experimental data for the 3-week and 9-week passages. We were particularly interested in better understanding the evolution of a viral population composed by two different viral types, the wild-type and one containing a duplication. The model consists of two coupled ordinary differential equations: $$\frac{dA}{dt} = aA\left( {1 - \frac{A + \beta B}{\kappa}} \right) - \delta A$$$$\frac{dB}{dt} = bB\left( {1 - \frac{\alpha A + B}{\kappa}} \right) + \delta A$$ where *A* is the number of viruses containing a gene duplication, *B* is the number of viruses that had reverted to the wild-type with a single copy, *a* is the initial growth rate of type *A* virus, *b* is the initial growth rate of the type *B*, *β* = *b/a* is a constant for determining the effect of the presence of *B* on replication of *A* ([@evw219-B37]), *α* = 1/*β* is a constant for determining the opposing effect of *A* on *B*, *κ* is the time-dependent carrying capacity of the host plant, and *δ* is the recombination rate per genome and replication at which the extra copy of the gene is removed from *A* to produce *B*. We assume that *κ* increases linearly over time, being proportional to the estimated weight of collected plant tissue (2 g for the whole plant at inoculation, 200 g for the collected leaves at 9 weeks). At the start of each round of infection, there is a fixed bottleneck size of *λ*. The number of infecting virions of *A* is determined by a random draw from a Binomial distribution with a probability of success *λA*/(*A* +*B*) and a size *λ*, and the number of infecting virions of *B* is then *λ* minus this realization from the Binomial distribution.

Estimates of most model parameters could be obtained from previous studies ([table 1](#evw219-T1){ref-type="table"}). An estimate of *b* has been made ([@evw219-B52]), whilst *a* can be determined knowing the competitive fitness of the virus with duplication relative to the wild-type virus. The value of *b* used is 1.344, and *a* values are 1.175, 1.234, 1.185, and 1.134 for TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~, TEV-NIb~1~-NIb~9~, and TEV-NIb~2~-NIb~9~, respectively. The only model parameter that needed to be estimated from the data is *δ*. To obtain an estimate of this parameter, we implemented the model as described in [equations (1)](#E1){ref-type="disp-formula"} and [(2)](#E2){ref-type="disp-formula"} in R 3.1.0. For each dataset to which we wanted to fit the model, we first simply ran the model for a wide range of recombination rates: considering all values of log(*δ*) between −20 and −0.1, with intervals of 0.1. One-thousand simulations were run for each parameter value.

###### 

Model Parameters

  Parameter             Value       Explanation
  --------------------- ----------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  λ                     500         Number of founders of infection ([@evw219-B53]).
  κ~*t\ =\ 9\ weeks*~   4 × 10^9^   Final value time-varying carrying capacity (9 weeks post-infection), weight of leaves multiplied by carrying capacity as estimated ([@evw219-B52]).
  *b*                   1.344       Initial growth rate (per generation) for virus with single gene copy ([@evw219-B52]).
  *a*                   ϕ*b*        Initial growth rate for virus with a duplicated gene, where *ϕ* is the relative fitness of the virus with duplications compared with the virus with a single gene copy (see results)
  g                     2.91        Generations per day ([@evw219-B29]).
  β                     *b*/*a*     The effect of *A* the replication of *B*
  α                     *a*/*b*     The effect of *B* the replication of *A*

To fit the model to the data, we considered model predictions of the frequency of three kinds of virus populations over time: (i) those populations containing only the full-length ancestral virus with a gene duplication (*X*~1~), (ii) those populations containing only variants with a genomic deletion removing the artificially introduced second gene copy (*X*~2~), and (iii) those populations containing a mixture of both variants (*X*~3~). Recombination and selection are modeled as deterministic processes, and therefore in every population recombinants will occur and be under selection. However, in order to reach appreciable frequencies and eventually be fixed, recombinants must reach a high enough frequency so that they will be sampled during the genetic bottleneck at the start of infection. Moreover, we used a PCR-based method with inherent limits to its sensitivity to characterize experimental populations. For these two reasons, we assumed that the predicted frequency of *A* must be greater than 0.1 and less than 0.9 to be considered a mixture. We then compared model predictions for the frequency of the three different kinds of virus populations with the data by means of multinomial likelihoods. The likelihood of the number of occurrences of these three stochastic variables denoting observations of a particular kind of population (*X*~1~, *X*~2~, and *X*~3~) follows a Multinomial distribution with probabilities *p*~1~, *p*~2~, and *p*~3~ (${\sum_{i = 1}^{3}p_{i}} = 1$). The multinomial probability of a particular realization (*x*~1~, *x*~2~, and *x*~3~) is given by: $$P\left( {X_{1} = x_{1},X_{2} = x_{2},X_{3} = x_{3}} \right) = \frac{\left( {\sum_{i = 1}^{3}x_{i}} \right)!}{\Pi_{i = 1}^{3}{x_{i}!}}{\underset{i = 1}{\overset{3}{\Pi}}p_{i}^{x_{i}}}.$$

The estimate of *δ* is then simply the value that corresponds to the lowest negative log-likelihood (NLL), for the entire range of *δ* values tested. We first fitted the model with a single value of *δ* to all the data (Model 1; 1 parameter). Next, we fitted the model with a virus-dependent value of *δ*, but one which is independent of passage duration (Model 2; 4 parameters). We then fitted the model with *δ* value dependent on passage duration, but the same for each virus (Model 3; 2 parameters). Finally, we fit the model to each experimental treatment separately (Model 4; 8 parameters). For all these different model fittings, 95% fiducial estimates of *δ* were obtained by fitting the model to 1000 bootstrapped datasets.

The numerical solutions of the differential [equations (1)](#E1){ref-type="disp-formula"} and [(2)](#E2){ref-type="disp-formula"} used to characterize the dynamical properties, build the phase portraits and to obtain the transient times ([supplementary text S2, Supplementary Material](#sup1){ref-type="supplementary-material"} online) have been obtained using a fourth-order Runge--Kutta method with a time step size 0.1.

Results
=======

Genetic Redundant Constructs and the Viability of the Resulting Viruses
-----------------------------------------------------------------------

To simulate the occurrence of duplication events within the TEV genome ([fig. 1A](#evw219-F1){ref-type="fig"}), different TEV genotypes were constructed using four genes of interest ([fig. 1](#evw219-F1){ref-type="fig"}). Each of these genotypes therefore represents a single gene duplication event. Where necessary, the termini of the duplicated gene copies were adjusted, such that the proteins can be properly translated and processed. Cleavage sites are provided, similar to the original proteolytic cleavage sites at the corresponding positions. A description of every duplication event will be given in the same order as these genes occur within the TEV genome.

First, for duplication of the multifunctional *HC-Pro* gene, a second copy of *HC-Pro* was inserted in the second position within the TEV genome, between the *P1* serine protease gene and the original *HC-Pro* copy, generating a tandem duplication ([fig. 1B](#evw219-F1){ref-type="fig"}). This position is a common site for the cloning of heterologous genes ([@evw219-B51]). Second, a copy of the *NIa-Pro* main viral protease gene was introduced between *P1* and *HC-Pro* ([fig. 1C](#evw219-F1){ref-type="fig"}). Third, two genotypes containing a duplication of the *NIb* replicase gene were generated ([@evw219-B49]), where a copy of the *NIb* gene was inserted at the first position (before *P1*) and the second position in the TEV genome ([fig. 1D](#evw219-F1){ref-type="fig"}). Fourth, for duplication of the *CP* we introduced a second copy at the tenth position between *NIb* and *CP*, generating a tandem duplication ([fig. 1E](#evw219-F1){ref-type="fig"}). Henceforth we refer to these five genetic redundant viruses as TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~, TEV-NIb~1~-NIb~9~, TEV-NIb~2~-NIb~9~, and TEV-CP~10~-CP~11~, respectively, with subscripts denoting the intergenic positions of the duplicated gene in question.

The viability of the genetic redundant viruses was tested in *N. tabacum* by inoculating plants with approximately 5 μg of *in vitro* generated transcripts ("Materials and Methods" section). The TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~, TEV-NIb~1~-NIb~9~, and TEV-NIb~2~-NIb~9~ viruses were found to infect *N. tabacum* plants, as determined by RT-PCR of total RNA extracted from these plants. Multiple viability tests showed that the TEV-CP~10~-CP~11~ virus had a very low infectivity and that large amounts of RNA (\>20 µg) were needed for a successful infection. When performing RT-PCR of the region containing the two *CP* copies, we detected either (i) a band corresponding to the wild-type virus, indicating that upon infection with RNA the second *CP* copy is deleted immediately, or (ii) a band that indicates the two *CP* copies are present. When taking the virus with the two *CP* copies as a starting population for experimental evolution, we found that this virus was highly unstable. Within the first 3-week passage, we detect a band corresponding to the wild-type virus, in six out of eight lineages, and we did not detect any infection in the remaining two lineages. When sequencing the region containing the deletions in the different lineages, using Sanger technology, exact deletions of the second *CP* copy were observed. We discontinued further experiments on this virus due to the extreme instability of the second *CP* copy.

Evolution of Genetically Redundant Viruses
------------------------------------------

After reconstitution of TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~, TEV-NIb~1~-NIb~9~, and TEV-NIb~2~-NIb~9~ from infectious clones, these viruses were evolved in *N. tabacum* plants for a total of 27 weeks, using nine 3-week passages and three 9-week passages with at least five independent lineages for each passage duration. In the starting population of TEV-HCPro~2~-HCPro~3~ we observed mild symptoms. However, in lineages from the first 3- and 9-week passages, the plants rapidly became as symptomatic as those infected by the wild-type virus. At the start of the evolution experiment, TEV-NIaPro~2~-NIaPro~8~ also displayed only mild symptoms and infection appeared to expand slower than for the wild-type TEV. However, in the first 9-week passage symptoms became stronger, similar to the wild-type virus, as the virus expanded through the plant. These stronger symptoms were also observed in the subsequent 9-week passages. Increases in symptom severity were also observed for the TEV-NIb~1~-NIb~9~ and TEV-NIb~2~-NIb~9~ viruses ([@evw219-B49]).

Partial and complete deletions of the duplicated gene copy were detected by RT-PCR ([fig. 2](#evw219-F2){ref-type="fig"}), but never in the ancestral gene. Rapid complete deletions were detected in all TEV-HCPro~2~-HCPro~3~ lineages ([fig. 2A](#evw219-F2){ref-type="fig"}). Note that no deletions were detected in the TEV-NIaPro~2~-NIaPro~8~ lineages using the shorter 3-week passages, whereas in the longer 9-week passages partial or complete deletions did occur in passage 2 ([fig. 2B](#evw219-F2){ref-type="fig"}). Mixed populations that contain viral genomes with a deletion together with genomes that have maintained the intact duplicated copy, are mainly present in the TEV-NIb~1~-NIb~9~ and TEV-NIb~2~-NIb~9~ lineages ([fig. 2C and D](#evw219-F2){ref-type="fig"}). Based on the majority deletion variants observed by RT-PCR, the genome size was estimated for every passage ([fig. 3](#evw219-F3){ref-type="fig"}). Comparing the genome size of the different viral genotypes in [figure 3](#evw219-F3){ref-type="fig"}, there are clear differences in the time until the duplicated gene copy is deleted. The duplicated *HC-Pro* appears the least stable, whereas the duplicated *NIa-Pro* appears to be the most stable. For TEV-NIaPro~2~-NIaPro~8~, TEV-NIb~1~-NIb~9~, and TEV-NIb~2~-NIb~9~, there are lineages that contain deletions that lead to a genome size smaller than that of the wild-type TEV.

![Deletion detection along the evolution experiments. RT-PCR was performed on the region containing a duplication in the viral genotypes (*A*--*D*). Either an intact duplicated copy (white boxes), a deletion together with an intact duplicated copy (light-grey boxes), or a partial or complete loss of the duplicated copy (dark-grey boxes) were detected.](evw219f2p){#evw219-F2}

![The reduction in genome size over time. The different panels display how the genome size of the different viral genotypes with gene duplications (*A*--*D*) changes along the evolution experiments. The dotted grey lines indicate the genome sizes of the wild-type virus (below) and the ancestral viruses (above). The genome sizes of the 3-week lineages are drawn with dashed black lines and open symbols, and those of the 9-week lineages are drawn with continuous blue lines and filled symbols.](evw219f3p){#evw219-F3}

Viruses with a Gene Duplication Have Reduced Fitness Which Cannot Always Be Fully Restored after Deletion
---------------------------------------------------------------------------------------------------------

For both the ancestral and evolved virus populations, we measured within-host competitive fitness ([fig. 4](#evw219-F4){ref-type="fig"}) and viral accumulation ([fig. 5](#evw219-F5){ref-type="fig"}). Comparing the ancestral viruses containing a gene duplication to the ancestral wild-type virus (solid circles in [figs. 4 and 5](#evw219-F4){ref-type="fig"}), we observed statistically significant decreases in competitive fitness ([fig. 4A](#evw219-F4){ref-type="fig"}: TEV-HCPro~2~-HCPro~3~: *t*~4~ = 8.398, *P* = 0.001; [fig. 4B](#evw219-F4){ref-type="fig"}: TEV-NIaPro~2~-NIaPro~8~: *t*~4~ = 12.776, *P* \< 0.001; [fig. 4C](#evw219-F4){ref-type="fig"}: TEV-NIb~1~-NIb~9~: *t*~4~ = 6.379, *P* = 0.003; TEV-NIb~2~-NIb~9~: *t*~4~ = 8.348, *P* = 0.001). Statistically significant decreases in accumulation levels were also observed for TEV-HCPro~2~-HCPro~3~, TEV-NIb~1~-NIb~9~, and TEV-NIb~2~-NIb~9~ ([fig. 5A](#evw219-F5){ref-type="fig"}: TEV-HCPro~2~-HCPro~3~: *t*~4~ = 3.491, *P* = 0.0251; [fig. 5C](#evw219-F5){ref-type="fig"}: TEV-NIb~1~-NIb~9~: *t*~4~ = 45.097, *P* \< 0.001; TEV-NIb~2~-NIb~9~: *t*~4~ = 8.650, *P* \< 0.001). However, there was no difference in accumulation for the virus with a duplication of *NIa-Pro* ([fig. 5B](#evw219-F5){ref-type="fig"}: TEV-NIaPro~2~-NIaPro~8~: *t*~4~ = 2.099, *P* = 0.104). All the four viruses with a gene duplication therefore have a reduced within-host competitive fitness, and three out of four viruses also have reduced accumulation levels. None of the possible benefits of these gene duplications therefore can compensate for their costs.

![Within-host competitive fitness of the evolved and ancestral lineages. Fitness (*W*), as determined by competition experiments and RT-qPCR of the different viral genotypes with respect to a common competitor; TEV-eGFP. The ancestral lineages are indicated by filled circles and the evolved lineages by open circles. The different viral genotypes are color coded, where the wild-type virus is drawn in green. The asterisks indicate statistical significant differences of the evolved lineages as compared with their corresponding ancestral lineages (*t*-test with Holm--Bonferroni correction).](evw219f4p){#evw219-F4}

![Virus accumulation of the evolved and ancestral lineages. Virus accumulation, as determined by accumulation experiments and RT-qPCR at 7 dpi of the different viral genotypes. The ancestral lineages are indicated by filled circles and the evolved lineages by open circles. The different viral genotypes are color coded, where the wild-type virus is drawn in green. The asterisks indicate statistical significant differences of the evolved lineages as compared with their corresponding ancestral lineages (*t*-test with Holm--Bonferroni correction).](evw219f5p){#evw219-F5}

After evolving the viruses with gene duplications using three 9-week passages, within-host competitive fitness of all four viruses increased (open circles in [fig. 4](#evw219-F4){ref-type="fig"}), compared with their respective ancestral viruses ([fig. 4](#evw219-F4){ref-type="fig"}; asterisks indicate a significant increase, *t*-test with Holm--Bonferroni correction for multiple tests). When comparing the evolved lineages, within-host fitness for TEV-HCPro~2~-HCPro~3~ ([fig. 4A](#evw219-F4){ref-type="fig"}) and TEV-NIaPro~2~-NIaPro~8~ ([fig. 4B](#evw219-F4){ref-type="fig"}) was similar to that of the wild-type TEV. On the other hand, the evolved TEV-NIb~1~-NIb~9~ and TEV-NIb~2~-NIb~9~ lineages did not reach wild-type virus within-host fitness levels ([fig. 4C](#evw219-F4){ref-type="fig"}). The within-host fitness of evolved lineages was compared by means of a nested ANOVA ([table 2](#evw219-T2){ref-type="table"}), allowing the independent lineages (at least 5) to be nested within the genotype and the independent plant replicates (3) to be nested within the independent lineages within the genotype. The nested ANOVA confirms that there is indeed an effect of the genotype for the TEV-NIb~1~-NIb~9~ and TEV-NIb~2~-NIb~9~ viruses ([table 2](#evw219-T2){ref-type="table"}; [@evw219-B49]), whereas for the TEV-HCPro~2~-HCPro~3~ and TEV-NIaPro~2~-NIaPro~8~ no effect was found. In summary, the fitness of TEV-HCPro~2~-HCPro~3~ and TEV-NIaPro~2~-NIaPro~8~ clearly increases to levels similar to the wild-type, whilst fitness did not increase for TEV-NIb~2~-NIb~9~ and TEV-NIb~1~-NIb~9~.

###### 

Nested ANOVA s on Within-Host Competitive Fitness and Viral Accumulation

  Genotype                  Trait                                  Source of variation   SS      df              MS        *F*       *P*
  ------------------------- -------------------------------------- --------------------- ------- --------------- --------- --------- ---------
  TEV-HCPro~2~-HCPro~3~     Competitive fitness                    Genotype              0.049   1               0.049     0.786     0.396
                            Lineage within genotype                0.624                 10      0.062           9.947     \<0.001   
                            Plant within lineage within genotype   0.150                 24      0.006           347.244   \<0.001   
                            Error                                  0.001                 72      1.81 × 10^−5^                       
  Accumulation              Genotype                               0.008                 1       0.008           0.080     0.783     
                            Lineage within genotype                1.012                 10      0.101           1.005     0.467     
                            Plant within lineage within genotype   2.417                 24      0.101           51.187    \<0.001   
                            Error                                  0.142                 72      0.002                               
  TEV-NIaPro~2~-NIaPro~8~   Competitive fitness                    Genotype              0.155   1               0.155     4.534     0.066
                            Lineage within genotype                0.274                 8       0.034           4.285     0.004     
                            Plant within lineage within genotype   0.160                 20      0.008           503.714   \<0.001   
                            Error                                  0.001                 60      1.59 × 10^−5^                       
  Accumulation              Genotype                               0.246                 1       0.246           1.199     0.305     
                            Lineage within genotype                1.643                 8       0.205           2.224     0.070     
                            Plant within lineage within genotype   1.847                 20      0.092           323.631   \<0.001   
                            Error                                  0.017                 60      0.001                               
  TEV-NIb~1~-NIb~9~         Competitive fitness                    Genotype              1.308   1               1.308     49.734    \<0.001
                            Lineage within genotype                0.212                 8       0.026           3.145     0.018     
                            Plant within lineage within genotype   0.169                 20      0.008           175.319   \<0.001   
                            Error                                  0.003                 58      4.81 × 10^−5^                       
  Accumulation              Genotype                               5.374                 1       5.374           36.006    \<0.001   
                            Lineage within genotype                1.194                 8       0.149           0.939     0.507     
                            Plant within lineage within genotype   3.178                 20      0.159           263.098   \<0.001   
                            Error                                  0.036                 60      0.001                               
  TEV-NIb~2~-NIb~9~         Competitive fitness                    Genotype              1.796   1               1.796     36.175    \<0.001
                            Lineage within genotype                0.397                 8       0.050           4.207     0.004     
                            Plant within lineage within genotype   0.236                 20      0.012           519.611   \<0.001   
                            Error                                  0.001                 60      2.27 × 10^−5^                       
  Accumulation              Genotype                               0.824                 1       0.824           3.728     0.090     
                            Lineage within genotype                1.771                 8       0.221           3.439     0.012     
                            Plant within lineage within genotype   1.290                 20      0.065           110.478   \<0.001   
                            Error                                  0.034                 59      0.001                               

Together with within-host fitness, virus accumulation also increased significantly for the evolved TEV-NIb~1~-NIb~9~ and TEV-NIb~2~-NIb~9~ virus lineages ([fig. 5C](#evw219-F5){ref-type="fig"}; asterisks), when compared with their respective ancestral viruses. However, accumulation levels did not increase significantly for most of the evolved lineages of the TEV-HCPro~2~-HCPro~3~ and TEV-NIaPro~2~-NIaPro~8~ genotypes. Nevertheless, these two genotypes have much higher initial accumulation levels than the genotypes with a duplication of the *NIb* gene. When comparing the accumulation levels of the evolved lineages to those of the wild-type, TEV-HCPro~2~-HCPro~3~ ([fig. 5A](#evw219-F5){ref-type="fig"}), TEV-NIaPro~2~-NIaPro~8~ ([fig. 5B](#evw219-F5){ref-type="fig"}), and TEV-NIb~2~-NIb~9~ ([fig. 5C](#evw219-F5){ref-type="fig"}) do reach wild-type accumulation levels, whereas TEV-NIb~1~-NIb~9~ does not ([fig. 5C](#evw219-F5){ref-type="fig"}). Comparing the accumulation levels of the evolved lineages by means of a nested ANOVA ([table 2](#evw219-T2){ref-type="table"}) confirms that there is an effect of the genotype for the TEV-NIb~1~-NIb~9~ virus ([table 2](#evw219-T2){ref-type="table"}; [@evw219-B49]), whereas no effect for the TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~, and TEV-NIb~2~-NIb~9~ viruses was found.

When comparing the within-host competitive fitness of the evolved TEV-NIaPro~2~-NIaPro~8~ 9-week lineages to the 3-week lineages, we found that there is a linear relationship between genome size and within-host competitive fitness ([fig. 6](#evw219-F6){ref-type="fig"}; Spearman's rank correlation *ρ* = −0.795, 10 d.f., *P* = 0.006). The evolved 9-week lineages, that contain genomic deletions, have a significant higher within-host competitive fitness (Mann--Whitney *U* = 4.5, *P* \< 0.001) than the evolved 3-week lineages without deletions.

![The relationship between genome size and within-host competitive fitness. The pink filled circle represents the within-host competitive fitness of the ancestral TEV-NIaPro~2~-NIaPro~8~ and the green filled circle that of the ancestral wild-type TEV. The black open circles represent the evolved 3-week (right) and 9-week (left) TEV-NIaPro~2~-NIaPro~8~ lineages. The evolved 9-week lineages, that contain genomic deletions, have a significant higher within-host competitive fitness (Mann--Whitney *U* = 4.5, *P* \< 0.001) than the evolved 3-week lineages without deletions. A linear regression has been drawn to emphasize the trend in the data.](evw219f6p){#evw219-F6}

Genome Sequences of the Evolved Lineages
----------------------------------------

All evolved and ancestral lineages have been fully sequenced using the Illumina technology. The sequences of the ancestral lineages were used as an initial reference for the evolved lineages. Furthermore, for the lineages where deletions were detected by RT-PCR ([fig. 3](#evw219-F3){ref-type="fig"}), parts of the genome were sequenced by Sanger to determine the exact deletion sites. The majority deletions variants were used to construct new reference sequences for each of the evolved TEV-HCPro~2~-HCPro~3~, TEV-NIaPro~2~-NIaPro~8~, TEV-NIb~1~-NIb~9~, and TEV-NIb~2~-NIb~9~ lineages that contain deletions. After an initial mapping step, mutations were detected in the evolved lineages as compared with their corresponding ancestor ("Materials and Methods" section). Beside the large genomic deletions, different patterns of adaptive evolution were observed for each viral genotype ([fig. 7](#evw219-F7){ref-type="fig"} and [table 3](#evw219-T3){ref-type="table"}). For a more detailed description of the mutations detected, see [supplementary text S1 (Supplementary Material](#sup1){ref-type="supplementary-material"} online). After remapping the cleaned reads against a new defined consensus sequence for each lineage, we looked at the variation within each lineage. Single nucleotide polymorphisms (SNPs) were detected at a frequency as low as 1%. In all four virus genotypes as well as in the wild-type virus, most of the SNPs were present at low frequency (frequency of SNPs at \< 0.1: TEV-HCPro~2~-HCPro~3~ = 89.8%; TEV-NIaPro~2~-NIaPro~8~ = 84.8%; TEV-NIb~1~-NIb~9~ = 83.3%; TEV-NIb~2~-NIb~9~ = 81.2%; TEV = 85.2%), with a higher prevalence of synonymous (TEV-HCPro~2~-HCPro~3~: 54.7%, TEV-NIaPro~2~-NIaPro~8~: 57.7%, TEV-NIb~1~-NIb~9~: 66.4%, TEV-NIb~2~-NIb~9~: 64.5%, TEV: 59.7%) versus non-synonymous changes ([supplementary fig. S1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Moreover, a percentage of the non-synonymous changes for TEV-HCPro~2~-HCPro~3~ (16.7%) and TEV-NIaPro~2~-NIaPro~8~ (7.3%) as well as the wild-type TEV (14.8%), are actually leading to stop codons and therefore unviable virus variants. In the lineages of both TEV-HCPro~2~-HCPro~3~ and TEV-NIaPro~2~-NIaPro~8~, there are significant differences in the distribution of the frequency of synonymous and non-synonymous SNPs per nucleotide position (Kolmogorov--Smirnov test; TEV-HCPro~2~-HCPro~3~: *D* = 0.219, *P* \< 0.001; TEV-NIaPro~2~-NIaPro~8~: *D* = 0.151, *P* = 0.009), whereas for TEV-NIb~1~-NIb~9~ and TEV-NIb~2~-NIb~9~ ([@evw219-B49]) and the wild-type virus this is not significant (Kolmogorov--Smirnov test; TEV: *D* = 0.084, *P* = 0.555). For more details on the frequency of the SNPs within every lineage, see [supplementary tables S3--S5](#sup1){ref-type="supplementary-material"} ([Supplementary Material](#sup1){ref-type="supplementary-material"} online).

![Genomes of the ancestral and evolved lineages. Mutations were detected using NGS data of the evolved virus lineages as compared with their ancestral lineages. The square symbols represent mutations that are fixed (\>50%) and the circle symbols represent mutations that are not fixed (\<50%). Filled symbols represent non-synonymous substitutions and open symbols represent synonymous substitutions. Black substitutions occur only in one lineage, whereas color-coded substitutions are repeated in two or more lineages, or in a lineage from another virus genotype. Note that the mutations are present at different frequencies as reported by SAMtools. Grey boxes indicate genomic deletions in the majority variant.](evw219f7p){#evw219-F7}

###### 

Adaptive Convergent Mutations within Each Virus Genotype

  Virus genotype            nt change at ancestral position   aa change   gene         nt position in gene
  ------------------------- --------------------------------- ----------- ------------ ---------------------
  TEV-HCPro~2~-HCPro~3~     A304G                             I→V         P1           160
                            U4444C                            S→P         P3           625
  TEV-NIaPro~2~-NIaPro~8~   C1466U                            S→L         NIa-Pro~2~   410
                            A4357G                            I→V         6K1          148
  TEV-NIb~1~-NIb~9~         A1643U                            Y→F         NIb~1~       1499
  TEV-NIb~2~-NIb~9~         C6351U                            Y→Y         CI           1173

nt: nucleotide; aa: amino acid.

Genomic Stability of TEV with Duplications of Homologous Genes
--------------------------------------------------------------

To better understand the evolutionary dynamics of viruses with gene duplications, we developed a simple mathematical model of virus competition and evolution. Based on amplicon sizes, the genome size for all evolved lineages was estimated for every passage ([fig. 3](#evw219-F3){ref-type="fig"}). Our model attempts to account for these data, and specifically how long the duplicated gene copy is maintained in the virus population. The model we developed describes how a population composed initially of only a virus variant with a gene duplication (variant *A*) through recombination, selection, and genetic drift acquires and eventually fixes a new variant that only retains the original copy of the duplicated gene (variant *B*). The model includes a genetic bottleneck at the start of each round of passaging (i.e., the initiation of infection in the inoculated leaf), with a fixed total number of founders and binomially distributed number of founders for variants containing the gene duplication. Following this genetic bottleneck, there is deterministic growth of both variants as well as deterministic recombination of *A* into *B*. The main question we addressed is whether knowing the fitness of duplicated viruses (i.e., *a*) is sufficient information to predict the stability of the inserted gene. Or do the data support a context-dependent recombination rate, with the context being (i) identity and position of the duplication, (ii) passage length, or (iii) both? We considered four different situations that are represented in the following models: "Model 1: one recombination rate for all conditions (1 parameter);Model 2: virus-genotype-dependent recombination rate (4 parameters);Model 3: passage-duration-dependent recombination rates (2 parameters);Model 4: virus-genotype- and passage-duration-dependent recombination rates (full model, 8 parameters)."

The model estimates of *δ* are given in [table 4](#evw219-T4){ref-type="table"}. Note that the parameter is often a minimum (when the virus is very unstable) or a maximum value (when the virus is very stable). If the optimum is represented by more than one parameter value (i.e., a range of parameter values that correspond to the lowest NLL), the mean of these values is given. Some of the models fit the data well ([table 5](#evw219-T5){ref-type="table"}), and we therefore saw no reason to explore more complex models of virus evolution. When comparing these models, we found that Model 2 is the best-supported model ([table 5](#evw219-T5){ref-type="table"}). Thus, only a genotype-dependent recombination rate is required to account for the data. The results strongly suggest that the fitness of a virus with a gene duplication does not provide sufficient information for predicting genomic stability. Rather, as the recombination rate is dependent on the genetic context, the supply of recombinants which have lost the duplicated gene will vary greatly from one genotype to another. High recombinogenic sites will remove the second copy fast, whereas low recombinogenic sites will preserve the copy for longer periods of time, after which it will be unavoidably removed, as confirmed by the numerical analysis of [equations (1)](#E1){ref-type="disp-formula"} and [(2)](#E2){ref-type="disp-formula"} ([supplementary text S2, Supplementary Material](#sup1){ref-type="supplementary-material"} online).

###### 

Model Parameter Estimates for Deterministic Recombination Rate

  Model                                              Estimates of Log~10~\[δ\] (Lower 95% fiducial limit, upper 95% fiducial limit)                                                                                                        
  -------------------------------------------------- -------------------------------------------------------------------------------- ------------------------------------------------- -------------------------------------------------- ----------
  1                                                  −6.2 ([\*](#evw219-TF2){ref-type="table-fn"})                                                                                                                                         
  2                                                  2HCPro                                                                           2NIaPro                                           2NIb1                                              2NIb2
  ≥ −3.0 ([\*](#evw219-TF2){ref-type="table-fn"})    = −9.65 (−10.1, −9.0)                                                            ≥ −2.9 ([\*](#evw219-TF2){ref-type="table-fn"})   = −4.45 (−5.2, −3.7)                               
  3                                                  3W                                                                               9W                                                                                                   
  = −6.2 ([\*](#evw219-TF2){ref-type="table-fn"})    = −9.65 (−10.1, −7.5)                                                                                                                                                                 
  4                                                  2HCPro 3W                                                                        2NIaPro 3W                                        2NIb1 3W                                           2NIb2 3W
  ≥ −3.0 ([\*](#evw219-TF2){ref-type="table-fn"})    ≤ −9.0 ([\*](#evw219-TF2){ref-type="table-fn"})                                  ≥ −2.9 ([\*](#evw219-TF2){ref-type="table-fn"})   = −4.45 (−5.5, −3.7)                               
  2HCPro 9W                                          2NIaPro 9W                                                                       2NIb1 9W                                          2NIb2 9W                                           
  ≥ −10.5 ([\*](#evw219-TF2){ref-type="table-fn"})   = −9.6 (−10.1, −7.5)                                                             ≥ −10.1                                           ≥ −11.5 ([\*](#evw219-TF2){ref-type="table-fn"})   

\*The fiducial limit is identical to the parameter estimate, also when the parameter estimate is a range, 2HCPro: TEV-HCPro~2~-HCPro~3~; 2NIaPro: TEV-NIaPro~2~-NIaPro~8~; 2NIb1: TEV-NIb~1~-NIb~9~; 2NIb2: TEV-NIb~2~-NIb~9~; 3W: 3-week passages; 9W: 9-week passages.

###### 

Model Selection for Models with Deterministic Recombination

  Model   Parameters   NLL       AIC       ΔAIC      Akaike Weight
  ------- ------------ --------- --------- --------- ---------------
  1       1            254.284   510.569   443.470   0.000
  2       4            29.549    67.099    −0.000    0.982
  3       2            226.669   457.339   390.240   0.000
  4       8            29.549    75.099    8.000     0.018

On the other hand, passage duration has a strong effect on the observed stability of gene duplications. However, model selection shows that this phenomenon can be sufficiently explained by considering the combined effects of selection and genetic drift, and without invoking passage-duration-dependent recombination rates. Given that recombination and selection are deterministic in the model, deletion variants will always arise during infection. However, depending on the rates of recombination and selection, these deletion variants may not reach a high enough frequency to ensure they are sampled during the genetic bottleneck at the start of each round of infection. This effect will be much stronger in the 3-week passages---because there will be fewer recombinants and less time for selection to increase their frequency---explaining why for some viruses there is such a marked difference in the observed genomic stability for different passage lengths.

The deterministic dynamics of the evolutionary model of stability of genomes containing gene duplications have also been investigated ([supplementary text S2, Supplementary Material](#sup1){ref-type="supplementary-material"} online). These analyses were performed on the model as described in [equations (1)](#E1){ref-type="disp-formula"} and [(2)](#E2){ref-type="disp-formula"}, albeit with a time-independent carrying capacity. The stability of three fixed points was analyzed: (i) the extinction of both *A* and *B*, (ii) the domination of *B* over the population, and (iii) the coexistence of *A* and *B* in the population. The fixed points analysis indicates that when *a* \<*b* and *δ \> a -- b*, the *B* virus subpopulation will outcompete the *A* subpopulation. This parametric combination is the one obtained using the biologically meaningful parameter values shown in [table 1](#evw219-T1){ref-type="table"}. This means that, under the model assumptions, the population of virus variants containing a gene duplication is unstable, and the population will be asymptotically dominated by virus variants containing a single gene copy. Notice that, the rate of recombination (*δ*) is also involved in this process of out-competition (see the bifurcation values calculated in [supplementary text S2, Supplementary Material](#sup1){ref-type="supplementary-material"} online). Specifically, if *δ* \> *a* -- *b*, coexistence of the two virus variants is not possible. Interestingly, the model also reveals the existence of a transcritical bifurcation separating the scenario between coexistence of the two variants and dominance of *B*. Such a bifurcation can be achieved by tuning *δ* as well as by unbalancing the fitness of *A* and *B* virus types. This bifurcation gives place to a smooth transition between these two possible evolutionary asymptotic states (i.e., unstable *A* population and coexistence of *A* and *B* populations). The bifurcation will take place when *a* =*b + δ*, or when *δ* is above a critical threshold, *δ~c~ = a* -- *b*, that can be calculated from the mathematical model ([supplementary text S2, Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Finally, we characterized the time to extinction of the *A* subpopulation. We characterized these extinction times as a function of viral fitness and of *δ*. Such a time is found to increase super-exponentially as the fitness of the *A* subpopulation, approaches the fitness of the *B* subpopulation. This effect is found for low values of recombination rates, similar to those shown in [table 4](#evw219-T4){ref-type="table"}. As expected, increases in *δ* produce a drastic decrease in the time needed for the single-copy variants to outcompete the variants with a gene duplication within the population ([supplementary text S2, Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Discussion
==========

Present-day viruses display a great variation in genome size and structure, indicating that gene duplication must have played a role in the early diversification of virus genomes. However, nowadays gene duplications are rarely documented in viruses, especially in RNA viruses. Therefore, it is quite obvious to expect *a priori* that genomes with gene duplications will be unstable in present-day RNA viruses. However, precise gene duplications occur never or only rarely in nature, and as our model virus encodes for a polyprotein, partial gene duplications are most likely to be non-functional. The engineered viruses in this study, removed that hurdle and therefore we expected that there was a higher probability of the introduced gene duplications contributing to the enhancement of a virus function or even the exploration of new functions. Nevertheless, none of the duplication events explored in this study appeared to be beneficial for TEV, both in terms of their immediate effects and second-order effects on evolvability. Gene duplication resulted in either an unviable virus or a significant reduction in viral fitness. In all cases, the duplicated gene copy, rather than the ancestral gene copy, was deleted during long-duration passages. The earlier detection and more rapid fixation of deletion variants during longer-duration passages is congruent with results from a previous study ([@evw219-B53]), where deletions of *eGFP* marker inserted in the TEV genome were usually observed after a single 9-week passage, but were rarely spotted even after nine 3-week passages. In this study, similar results were obtained for TEV-NIaPro~2~-NIaPro~8~ where no deletions were spotted in the 3-week passages. On the other hand, the highly divergent results reported here for the stability of different duplicated genes suggest that passage duration is not the main factor determining whether gene duplication will be stable or unstable. Therefore, we postulated that the size of the duplicated gene, the nature of the gene, and/or the position for duplication could play a role in the stability of genomes containing a gene duplication.

The observation that gene duplication events result in decreases in fitness is not unexpected. The high mutation rate of RNA viruses is likely to constrain genome size ([@evw219-B18]), given that most mutations are deleterious ([@evw219-B32]; [@evw219-B13]). This imposes the evolution of genome compression, where overlapping reading frames play a major role ([@evw219-B4]). In our model virus, we speculate that the fitness cost can be related to three processes: (i) the increase in genome size, (ii) the extra cost of more proteins being expressed in the context of using more cellular resources, and (iii) a disturbance in correct polyprotein processing. Although all the duplications considered here could conceivably have advantages for viral replication or encapsidation, our results suggest that the any such advantages are far outweighed by the costs associated with a larger genome, increased protein expression or the effects on polyprotein processing. However, the duplication of *NIa-Pro* does not affect the viral accumulation rate. This could be explained by the fact that the *NIa-Pro* gene is much smaller than the other duplicated genes. Consequently, in conditions where selection has the least time to act between bottleneck events associated with infection of a new host (3-week passages), no deletions were observed. In the long-passage experiment, selection has more time to act and increase the frequency of beneficial *de novo* variants, allowing them to be sampled during the bottleneck at the start of the next round of infection. In addition, the size of the gene duplication also seems to play a role. But what about the position and the nature of the duplicated gene? When duplicating the same gene, *NIb*, to either the first or second position in the TEV genome, we see clear differences in the deletion dynamics and fitness measurements ([figs. 3--5;](#evw219-F3){ref-type="fig"}[@evw219-B49]). Comparing the duplication and subsequent deletion of *HC-Pro*, *NIa-Pro* and *NIb* at the same second position, we observe that both accumulation and within-host competitive fitness cannot be completely restored by the virus that originally had two copies of the *NIb* replicase gene, whilst viruses that originally had two copies of the *HC-Pro* gene or the main viral protease *NIa-Pro* gene do restore their fitness after deletion. However, because our evolutionary experiments were limited to approximately half a year, we cannot rule out complete restoration of fitness over longer time periods.

At the sequence level, there were some convergent single-nucleotide mutations, although in most cases these occur only in a small fraction of lineages. The transient presence of the duplicated *NIa-Pro* copy in the 3-week lineages does seem to be linked to an adaptive mutation. However, our fitness measurements suggest that the cost of gene duplication cannot be overcome by this single nucleotide mutation. The main change in the evolved lineages is the deletion of the duplicated gene copy. However, some deletions extend beyond the duplicated gene copy, including the N-terminal region of the HC-Pro cysteine protease, similar to results obtained by previous studies ([@evw219-B12]; [@evw219-B53]; [@evw219-B49]). The N-terminal region of HC-Pro is implicated in transmission by aphids ([@evw219-B40]; [@evw219-B2]) and is not essential for viral replication and movement ([@evw219-B12]; [@evw219-B11]). Our experimental setup does not involve transmission by aphids, however, we do not observe this deletion when evolving the wild-type virus. Moreover, we only observe this deletion when the position of gene duplication or insertion ([@evw219-B53]) is before HC-Pro, suggesting that gene insertion and subsequent deletion at this position facilitates recombination to an even smaller genome size.

By fitting a mathematical model of virus evolution to the data, we found that knowing only viral fitness is not enough information to predict the stability of the duplicated genes: model selection suggests there is a context-dependent recombination rate, and specifically, the identity and position of the duplication also play a role. Given that the supply rate of variants with large deletions will be driven largely by homologous recombination, we had expected stability to depend on the genetic context. The estimates of the recombination rate per genome and generation in this study are far lower than previously reported for TEV, which was estimated to be 3.43 × 10^−5^ per nucleotide and generation ([@evw219-B43]), which translates into 0.327 per genome and generation. The estimates of this study (TEV-HCPro~2~-HCPro~3~: 1.00 × 10^−3^; TEV-NIaPro~2~-NIaPro~8~: 2.24 × 10^−10^; TEV-NIb~1~-NIb~9~: 1.26 × 10^−3^; TEV-NIb~2~-NIb~9~: 3.55 × 10^−5^) are much closer to the per nucleotide estimate. This large discrepancy could be related to two factors. [@evw219-B43]) considered recombination between two highly similar genotypes, which requires consideration of many details of the experimental system, including the rate at which cells will be coinfected by these genotypes. On the other hand, considering these details should lead to a general estimate of the recombination rate (as opposed to the rate at which two different genotypes will recombine in a mixed infection) and hence this explanation is not very satisfactory. Second, only a small fraction of all recombination events will render viruses with a conserved reading frame, and a suitable deletion size: large enough to have appreciable fitness gains and be selected, but small enough not to disrupt the surrounding cistrons or polyprotein processing. Therefore, the parameter *δ* described here is in fact the rate at which this particular subclass of recombinants occurs. This subclass is likely to be only a small fraction of all possible recombinants, and hence it is quite reasonable that these two estimates of the recombination rate vary by several orders of magnitude.

In addition to gene duplications, the model developed in this study can be applied to predict the stability of other types of sequence insertions, such as those brought about by horizontal gene transfer. Understanding the stability of gene insertions in genomes is highly relevant to the understanding genome-architecture evolution, but it also has important implications for biotechnological applications, such as heterologous expression systems. Our results here suggest that the fitness costs of extraneous sequences may not be a good predictor of genomic stability, in general. Therefore, in practical terms, it could be advisable to empirically test the stability of, e.g., a viral construct, rather than make assumptions on stability based on parameters such as replication or accumulation.
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